{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:47:53Z","timestamp":1762865273534},"reference-count":19,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,26]],"date-time":"2014-12-26T00:00:00Z","timestamp":1419552000000},"content-version":"vor","delay-in-days":2735,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1111\/j.1469-0691.2007.01717.x","type":"journal-article","created":{"date-parts":[[2007,4,2]],"date-time":"2007-04-02T16:00:55Z","timestamp":1175529655000},"page":"743-746","source":"Crossref","is-referenced-by-count":9,"title":["Activity of telithromycin and comparators against isolates of Legionella pneumophila collected from patients with community-acquired respiratory tract infections: PROTEKT Years 1\u20135"],"prefix":"10.1016","volume":"13","author":[{"given":"L.M.","family":"Dunbar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.J.","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.1469-0691.2007.01717.x_bib1","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF03256652","article-title":"Legionnaires' disease: update on epidemiology and management options","volume":"2","author":"Sabria","year":"2003","journal-title":"Am J Respir Med"},{"key":"10.1111\/j.1469-0691.2007.01717.x_bib2","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1086\/380488","article-title":"Update of practice guidelines for the management of community\u2010acquired pneumonia in immunocompetent adults","volume":"37","author":"Mandell","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01717.x_bib3","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1017\/S0950268804002018","article-title":"Legionnaires' disease in Europe 2000\u20132002","volume":"132","author":"Joseph","year":"2004","journal-title":"Epidemiol Infect"},{"key":"10.1111\/j.1469-0691.2007.01717.x_bib4","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1378\/chest.125.6.2135","article-title":"Levofloxacin efficacy in the treatment of community\u2010acquired legionellosis","volume":"125","author":"Yu","year":"2004","journal-title":"Chest"},{"key":"10.1111\/j.1469-0691.2007.01717.x_bib5","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1086\/341087","article-title":"Distribution of Legionella species and serogroups isolated by culture in patients with sporadic community\u2010acquired legionellosis: an international collaborative survey","volume":"186","author":"Yu","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01717.x_bib6","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/BF01695659","article-title":"Delay in appropriate therapy of Legionella pneumonia associated with increased mortality","volume":"15","author":"Heath","year":"1996","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01717.x_bib7","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jinf.2005.04.015","article-title":"Trends in anti\u2010bacterial resistance among Streptococcus pneumoniae isolated in the USA, 2000\u20132003: PROTEKT US years 1\u20133","volume":"51","author":"Jenkins","year":"2005","journal-title":"J Infect"},{"key":"10.1111\/j.1469-0691.2007.01717.x_bib8","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1128\/AAC.42.8.1944","article-title":"Interactions between HMR 3647, a new ketolide, and human polymorphonuclear neutrophils","volume":"42","author":"Vazifeh","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"issue":"suppl B","key":"10.1111\/j.1469-0691.2007.01717.x_bib9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/jac\/48.suppl_2.25","article-title":"Activity of telithromycin, a new ketolide antibacterial, against atypical and intracellular respiratory tract pathogens","volume":"48","author":"Hammerschlag","year":"2001","journal-title":"J Antimicrob Chemother"},{"issue":"suppl S1","key":"10.1111\/j.1469-0691.2007.01717.x_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkf807","article-title":"The need for antimicrobial resistance surveillance","volume":"50","author":"Felmingham","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2007.01717.x_bib11","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ijantimicag.2004.08.019","article-title":"Comparative activity of quinolones, macrolides and ketolides against Legionella species using in vitro broth dilution and intracellular susceptibility testing","volume":"25","author":"Stout","year":"2005","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/j.1469-0691.2007.01717.x_bib12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/jac\/46.1.51","article-title":"Antibacterial effect of telithromycin (HMR 3647) and comparative antibiotics against intracellular Legionella pneumophila","volume":"46","author":"Baltch","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2007.01717.x_bib13","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/jac\/dki186","article-title":"Antibacterial activities of gemifloxacin, levofloxacin, gatifloxacin, moxifloxacin, and erythromycin against intracellular Legionella pneumophila and Legionella micdadei in human monocytes","volume":"56","author":"Baltch","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2007.01717.x_bib14","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1128\/AAC.45.8.2204-2209.2001","article-title":"In vitro activity of gemifloxacin (SB\u2010265805, LB20304a) against Legionella pneumophila and its pharmacokinetics in guinea pigs with L. pneumophila pneumonia","volume":"45","author":"Edelstein","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01717.x_bib15","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1128\/AAC.40.2.314","article-title":"Activity of trovafloxacin (CP\u201099,219) against Legionella isolates: in vitro activity, intracellular accumulation and killing in macrophages, and pharmacokinetics and treatment of guinea pigs with L. pneumophila pneumonia","volume":"40","author":"Edelstein","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01717.x_bib16","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1086\/428059","article-title":"Clinical outcomes for hospitalized patients with Legionella pneumonia in the antigenuria era: the influence of levofloxacin therapy","volume":"40","author":"Mykietiuk","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01717.x_bib17","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1378\/chest.128.3.1401","article-title":"Fluoroquinolones vs macrolides in the treatment of Legionnaires disease","volume":"128","author":"Sabria","year":"2005","journal-title":"Chest"},{"key":"10.1111\/j.1469-0691.2007.01717.x_bib18","doi-asserted-by":"crossref","first-page":"605","DOI":"10.2165\/00003495-200565050-00003","article-title":"Treatment of Legionnaires' disease","volume":"65","author":"Amsden","year":"2005","journal-title":"Drugs"},{"key":"10.1111\/j.1469-0691.2007.01717.x_bib19","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1007\/s10096-004-1152-2","article-title":"Efficacy of telithromycin in community\u2010acquired pneumonia caused by Legionella pneumophila","volume":"23","author":"Carbon","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14633887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14633887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T00:08:12Z","timestamp":1556323692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14633887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S1198743X14633887"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-0691.2007.01717.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}